Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Guangzhou University of Traditional Chinese Medicine |
---|---|
Information provided by: | Guangzhou University of Traditional Chinese Medicine |
ClinicalTrials.gov Identifier: | NCT00547950 |
In order to observe the influence of the Dengzhan Shengmai Capsule on the endpoint of patients with ischemic stroke, we hold the multi-centered prospective cohort study. From November 2007 to December 2009, 12000 subjects are included in 200 clinical research centers all over China. The subjects naturally formed two cohorts based on taking Dengzhan Shengmai capsule or not. The basic therapy included antiplatelet aggregation , stroke health education, management of blood pressure, blood lipid and blood glucose, etc. Then all of the subjects are visited on the 360th day after inclusion. The recurrence of stroke, cardiovascular events, and peripheral arterial events are observed.
Condition | Intervention |
---|---|
Ischemic Stroke |
Drug: :Deng Zhan Sheng Mai Capsule |
Study Type: | Interventional |
Study Design: | Prevention, Non-Randomized, Open Label, Parallel Assignment |
Official Title: | A Model Study on the Comprehensive Treating Protocol of Secondary Prevention and Effect Evaluation of Ischemic Stroke With Traditional Chinese Medicine |
Estimated Enrollment: | 12000 |
Study Start Date: | November 2007 |
Estimated Study Completion Date: | October 2009 |
Arms | Assigned Interventions |
---|---|
1: Experimental
drug
|
Drug: :Deng Zhan Sheng Mai Capsule
capsule,0.18g,2#,po,Bid*1year.
|
Ages Eligible for Study: | 40 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Yan Huang, Bachelor | (08620) 81887233 ext 34530 | huang61@medmail.com.cn |
Contact: LIxin Wang, Doctor | (08620) 81887233 ext 34530 | plawlx@126.com |
China, Guangdong | |
Guangdong Province Hospital of Tradtional Chinese Medicine | |
Guangzhou, Guangdong, China, 510120 |
Principal Investigator: | Yan Huang, Bachelor | Guangdong Province Hospital of Tradtional Chinese Medicine |
Study ID Numbers: | 2006BAI04A02-2 |
Study First Received: | October 22, 2007 |
Last Updated: | October 28, 2007 |
ClinicalTrials.gov Identifier: | NCT00547950 History of Changes |
Health Authority: | China: Ethics Committee; China: Ministry of Health; China: State Food and Drug Administration |
Cerebral Infarction Stroke Vascular Diseases Neoplasm Metastasis |
Central Nervous System Diseases Ischemia Brain Diseases Cerebrovascular Disorders |
Pathologic Processes Nervous System Diseases Stroke Vascular Diseases Central Nervous System Diseases |
Cardiovascular Diseases Ischemia Brain Diseases Cerebrovascular Disorders |